IVIG is the largest selling plasma protein in the world. It is a mixture of naturally occurring human antibodies, which are critical for a healthy immune system. IVIG is used to treat a wide variety of clinical conditions related to disorders of the immune system. It has been approved for multiple indications such as:

  • B-cell chronic lymphocytic leukemia (CLL)
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Immune thrombocytopenic purpura (ITP)
  • Multifocal motor neuropathy (MMN)
  • Primary Immunodeficiency (PID)